Table 2.

Relation of the sociodemographic and disease-related properties of RA patients with BIS and SEI scores (n=120)

Variables	Variable categories	BIS		SEI
		Mean score ± SD	Test val.; p	Mean score ± SD	Test val.; p
Age	20–441	147.37±19.92	F=24.741	19.26±4.02	F=3.791
	45–592	120.96±20.09	p=0.001**	17.12±3.08	p=0.025*
	60–723	122.18 ±18.91	significant difference between group 1 and 2 and group 1 and 3	18.12±3.34	significant difference between group 1 and 2
Gender	Female	132.06±23.37	t=3.846	18.26±3.64	t=−1.261
	Male	149.38±18.91	p=0.001**	19.23±4.13	p=0.210
Education	Primary school1	122.48±19.80	F=12.24	17.48±3.41	F=6.167
	High school2	139.44±21.99	p=0.001**	17.80±3.66	p=0.003**
	Bachelor’s degree and higher3	146.20±22.37	significant difference between group 1 and 2 and group 1 and 3	20.06±3.79	Significant difference between group 1 and 3 and group 2 and 3
Treatment period	1–24 months1	144.00±21.18	F=2.967	19.56±3.69
	25–60 months2	139.65±16.74	p=0.045*	18.46±3.67	F=1.703
	≥ 61 months3	132.22±26.07	significant difference between group 1 and 3	18.04±3.85	p=0.187
About disease	Yes	146.65±20.00	t=−2.802	18.78±4.05	t=−0.415
Education status	No	133.45±23.74	p=0.006	18.45±3.72	p=0.679
Psychological	Yes	130.04±25.89	t=1.541	16.36±3.68	t=−3.080
Receiving assistance	No	138.53±22.74	p=0.126	19.03±3.66	p=0.003**
Additional	Yes	126.46±22.43	t=3.875	17.04±3.47	t=−3.358
morbidity	No	142.84±22.06	p=0.001**	19.37±3.73	p=0.001**
Anti-TNF	Yes	131.63±20.53	t=2.550	17.71±3.82	t=−2.427
Usage state	No	142.31±25.13	p=0.012*	19.36±362	p=0.017*
Use of Anti-TNF	1–24 months1	131.96±20.78		17.84±4.15
Period (n=60)	25–60 months2	130.33±19.47	KW=0.401	17.38±3.48	KW=0.308
	≥61 months3	134.00±25.23	p=0.818	18.14±3.62	p=0.857

F: One way variance analysis, KW: Kruskal Wallis test, t: student t test,

^*p<0 .05,

^**p<0 .01